BetterLife To Participate at the H.C. Wainwright 1st Annual Mental Health Conference
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Month: June 2022
ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney Disease
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) — ProKidney LP (ProKidney), a leading clinical-stage cellular…
Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes
LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical…
HMNC Brain Health to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond on June 27, 2022
MUNICH, Germany, June 23, 2022 (GLOBE NEWSWIRE) — HMNC Brain Health (“HMNC” or the “Company”),…
BioVie Announces Patent Issuance Covering Ascites Treatment with BIV201
CARSON CITY, Nev., June 23, 2022 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”), a…
Timber Pharmaceuticals Announces First Patients Enrolled in Phase 3 ASCEND Clinical Trial Evaluating TMB-001 in Congenital Ichthyosis
Pivotal Trial Expected to Enroll More Than 140 Patients With Moderate to Severe Congenital Ichthyosis…
SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)
Orders Received from Two New Jurisdictions, and a Country in the Asia Pacific Region under…
Cognition Therapeutics Doses First Patient with Dementia with Lewy Bodies in Phase 2 Clinical Study of CT1812
– Study Supported by $30M NIA Grant Award and Conducted in Collaboration with University of…
Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Cancer
COPENHAGEN, Denmark, June 23, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the…
uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
Bar Chart Bar Chart ~ Treatment generally well-tolerated with no significant safety issues related to…
Oncorus Appoints Douglas Fambrough to Board of Directors
-Former CEO of Dicerna brings deep expertise in RNA research, drug development, business development and…
Todos Medical Releases Preliminary Data From IRB-Waived Tollovid® Market Research Study in Acute and Long COVID
83% of Respondents With Acute COVID Were Satisfied 68% of Respondents With Long COVID Were…
Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer
WALTHAM, Mass., June 23, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board…
Manchester gets new affordable home and business Internet options from Verizon
Residents on Verizon’s premium unlimited plans can get Verizon Home Internet for just $25 per…
Hologram Brings New Level of Transparency to IoT Fleets with Connectivity Dashboard Analytics
Next-generation software gives businesses real-time analytics and control of their IoT fleets, reducing costs and…
QuestionPro Aims to Spur Global Innovation by Giving Away $5 Million of Free Research Software Subscriptions to 1,000 Startups
Company is partnering with incubators and accelerators around the globe AUSTIN, Texas, June 23, 2022…
Introducing Meshnet – NordVPN’s new feature allows users to create their own VPN server in seconds
The new feature lets you route your internet traffic through other devices over encrypted private…
Korea Blockchain Week to Hold First Live Event in Seoul After Covid Hiatus
Seoul, South Korea–(Newsfile Corp. – June 23, 2022) – Korea Blockchain Week 2022 (KBW2022) is…